ELEcushla Linedale

Ecushla Linedale

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ecushla Linedale has a total of 61 co-authors. Here are the top co-authors by number of shared publications:

  • Antonina Mikocka-Walus

    School of Psychology, Faculty of Health, Deakin University, Burwood, Australia

    2 shared publications
  • Jane M. Andrews

    Ecushla C. Linedale, PhD, The University of Adelaide, Adelaide, South Australia; and The South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia

    2 shared publications
  • Jörg Strobel

    College of Medicine and Public Health, Flinders University, Barossa Hills Fleurieu LHN, SA Health Adelaide South Australia Australia

    2 shared publications
  • Niranjan Bidargaddi

    Digital Psychiatry & Personal Health Informatics Lab, College of Medicine and Public Health, Flinders University, Adelaide, Australia

    2 shared publications
  • Peter R. Gibson

    Ecushla C. Linedale, PhD, The University of Adelaide, Adelaide, South Australia; and The South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia

    2 shared publications
  • Tarun Bastiampillai

    College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia

    2 shared publications

Latest Publications

  • Open Access

    Model-Based Cost-Effectiveness Analysis of Routine Omega-3 Testing and Targeted Supplementation to Reduce Early Preterm Birth in Australia Compared with Current Practice

    by Hossein Haji Ali Afzali, Ecushla Linedale, Craig Martin, Muktar Ahmed, Julie Quinlivan, Andrew McPhee, Penelope Coates, Lucas Semmler, David Cox, Robert Gibson, et al.

    Preterm birth remains a leading cause of newborn death, disability, and long-term health challenges globally, with a substantial impact on families, the health system, and society. Omega-3 supplementation in women with low omega-3 status in early pregnancy has been shown to reduce the risk of preterm birth, particularly early preterm birth (<34 weeks of gestation). The cost implications of incorporating omega-3 testing and targeted supplementation into routine antenatal care to reduce early preterm birth in Australia are unclear. A decision analytic model was developed using Australian epidemiological, clinical, and cost data to compare routine omega-3 testing and targeted supplementation with current practice. The model predicted the number of early preterm births prevented and associated cost savings over an 18-year time horizon. Deterministic sensitivity analyses were conducted to examine uncertainty in key model inputs. Among 289,195 singleton pregnancies in 2022, an estimated 17.5% of women would have low omega-3 status and be eligible for supplementation. Making conservative assumptions, the model predicted that, relative to current practice, omega-3 testing and supplementation would be a dominant strategy, preventing 640 early preterm births, with projected savings of $26.1 million in direct healthcare costs. Sensitivity analyses indicated that the results were robust across most scenarios and identified the treatment effect estimate as the strongest driver of model predictions. Omega-3 testing in early pregnancy with targeted supplementation may offer a scalable and cost-effective strategy to reduce early preterm birth with potential benefits for mothers, infants, and the health system. The modelling suggests meaningful health and economic benefits. Cost savings were robust across most plausible scenarios, supporting the potential value of this approach on a national scale.

  • Open Access

    Understanding Australian Consumers' Views on Health Information Use in Research: Systematic Review Protocol

    by Mehrsa Zakershahrak, Ecushla Linedale, Sarah Eley, Penelope McMillan, Lana Earle, Hannah Freeman, Wendy Keech

    Background Understanding consumers' and patients' expectations, perspectives, and understandings regarding the use of their health information for research purposes is essential to aligning research practices with public values and fostering trust in the research process. Objectives This unique systematic review aims to synthesise the existing literature on consumers' and patients' expectations regarding the use of their health information for research purposes in Australia, providing a comprehensive understanding of this crucial aspect of the research process. Methods A comprehensive search of electronic databases, including MEDLINE, EMBASE, Web of Science, and Scopus, for studies published in English from 2018 onwards will be conducted. Additionally, we will perform a grey literature search and screen Google Scholar. Studies will be screened and selected based on predefined inclusion and exclusion criteria. Data will be extracted, and the quality of included studies will be assessed using the Joanna Briggs Institute critical appraisal tools. A thematic synthesis approach will be used to analyse and summarise the data. Consumers will be engaged in multiple stages to guarantee that the research process is responsive to their concerns and reflects their viewpoints. Discussion The findings will provide insights into the transparency of the research process, consent, ownership, privacy protection, and limitations to using health data in research as perceived by consumers in Australia. This review will inform policymakers and researchers about public expectations and enhance ethical practices in health data usage for research. Systematic Review Registration: PROSPERO CRD42024514557

  • Open Access

    Which strategies support the effective use of clinical practice guidelines and clinical quality registry data to inform health service delivery? A systematic review

    by Kathy Dempsey, Caleb Ferguson, Adam Walczak, Sandy Middleton, Christopher Levi, Rachael L. Morton, on behalf of The Australian Health Research Alliance (AHRA) Health System Improvement and Sustainability Working Group members, Katherine Boydell, Megan Campbell, Alan Cass, et al.

    Background: Empirical evidence suggests data and insights from the clinical practice guidelines and clinical quality registries are not being fully utilised, leaving health service managers, clinicians and providers without clear guidance on how best to improve healthcare delivery. This lack of uptake of existing research knowledge represents low value to the healthcare system and needs to change. Methods: Five electronic databases (MEDLINE, Embase, CINAHL, Cochrane Central and Cochrane Database of Systematic Reviews) were systematically searched. Included studies were published between 2000 and 2020 reporting on the attributes, evidence usage and impact of clinical practice guidelines and clinical quality registries on health service delivery. Results: Twenty-six articles including one randomised controlled trial, eight before-and-after studies, eight case studies/reviews, five surveys and four interview studies, covering a wide range of medical conditions and conducted in the USA, Australia and Europe, were identified. Five complementary strategies were derived to maximise the likelihood of best practice health service delivery: (1) feedback and transparency, (2) intervention sustainability, (3) clinical practice guideline adherence, (4) productive partnerships and (5) whole-of-team approach. Conclusion: These five strategies, used in context-relevant combinations, are most likely to support the application of existing high-quality data, adding value to health service delivery. The review highlighted the limitations of study design in opportunistic registry studies that do not produce clear, usable evidence to guide changes to health service implementation practices. Recommendations include exploration of innovative methodologies, improved coordination of national registries and the use of incentives to encourage guideline adherence and wider dissemination of strategies used by successful registries.


  • Open Access

    Automated Decision Support For Community Mental Health Services Using National Electronic Health Records: Qualitative Implementation Case Study

    by Yasmin van Kasteren, Jörg Strobel, Tarun Bastiampillai, Ecushla Linedale, Niranjan Bidargaddi

    Background: A high proportion of patients with severe mental illness relapse due to nonadherence to psychotropic medication. In this paper, we use the normalization process theory (NPT) to describe the implementation of a web-based clinical decision support system (CDSS) for Community Mental Health Services (CMHS) called Actionable Intime Insights or AI2. AI2 has two distinct functions: (1) it provides an overview of medication and treatment history to assist in reviewing patient adherence and (2) gives alerts indicating nonadherence to support early intervention. Objective: Our objective is to evaluate the pilot implementation of the AI2 application to better understand the challenges of implementing a web-based CDSS to support medication adherence and early intervention in CMHS. Methods: The NPT and participatory action framework were used to both explore and support implementation. Qualitative data were collected over the course of the 14-month implementation, in which researchers were active participants. Data were analyzed and coded using the NPT framework. Qualitative data included discussions, meetings, and work products, including emails and documents. Results: This study explores the barriers and enablers of implementing a CDSS to support early intervention within CMHS using Medicare data from Australia’s national electronic record system, My Health Record (MyHR). The implementation was a series of ongoing negotiations, which resulted in a staged implementation with compromises on both sides. Clinicians were initially hesitant about using a CDSS based on MyHR data and expressed concerns about the changes to their work practice required to support early intervention. Substantial workarounds were required to move the implementation forward. This pilot implementation allowed us to better understand the challenges of implementation and the resources and support required to implement and sustain a model of care based on automated alerts to support early intervention. Conclusions: The use of decision support based on electronic health records is growing, and while implementation is challenging, the potential benefits of early intervention to prevent relapse and hospitalization and ensure increased efficiency of the health care system are worth pursuing.


  • Open Access

    Automated Decision Support For Community Mental Health Services Using National Electronic Health Records: Qualitative Implementation Case Study (Preprint)

    by Yasmin van Kasteren, Jörg Strobel, Tarun Bastiampillai, Ecushla Linedale, Niranjan Bidargaddi

    Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: A high proportion of patients with severe mental illness relapse due to nonadherence to psychotropic medication. In this paper, we use the normalization process theory (NPT) to describe the implementation of a web-based clinical decision support system (CDSS) for Community Mental Health Services (CMHS) called Actionable Intime Insights or AI2. AI2 has two distinct functions: (1) it provides an overview of medication and treatment history to assist in reviewing patient adherence and (2) gives alerts indicating nonadherence to support early intervention. Objective: Our objective is to evaluate the pilot implementation of the AI2 application to better understand the challenges of implementing a web-based CDSS to support medication adherence and early intervention in CMHS. Methods: The NPT and participatory action framework were used to both explore and support implementation. Qualitative data were collected over the course of the 14-month implementation, in which researchers were active participants. Data were analyzed and coded using the NPT framework. Qualitative data included discussions, meetings, and work products, including emails and documents. Results: This study explores the barriers and enablers of implementing a CDSS to support early intervention within CMHS using Medicare data from Australia’s national electronic record system, My Health Record (MyHR). The implementation was a series of ongoing negotiations, which resulted in a staged implementation with compromises on both sides. Clinicians were initially hesitant about using a CDSS based on MyHR data and expressed concerns about the changes to their work practice required to support early intervention. Substantial workarounds were required to move the implementation forward. This pilot implementation allowed us to better understand the challenges of implementation and the resources and support required to implement and sustain a model of care based on automated alerts to support early intervention. Conclusions: The use of decision support based on electronic health records is growing, and while implementation is challenging, the potential benefits of early intervention to prevent relapse and hospitalization and ensure increased efficiency of the health care system are worth pursuing.

  • The Potential of Integrated Nurse-Led Models to Improve Care for People With Functional Gastrointestinal Disorders

    by Ecushla C. Linedale, Antonina Mikocka-Walus, Peter R. Gibson, Jane M. Andrews

    Functional gastrointestinal disorders such as irritable bowel syndrome and functional dyspepsia are extremely common, debilitating, and costly. Although diagnostic guidelines and effective management options exist, management is suboptimal, with long waiting lists, delayed diagnosis, and poor patient outcomes. The aim of this systematic review was to explore and evaluate evidence for existing models of care for functional gastrointestinal disorders. Thirty-eight studies pertaining to the diagnosis or management of functional gastrointestinal disorders were found; however, only 6 investigated a full model of care. Five studies assessed a nurse-led model and 1 a structured gastroenterologist consultation. Nurse-led models were cheaper to current treatments and resulted in symptomatic improvement, high patient satisfaction, reduced healthcare usage, and improved psychosocial functioning and quality of life, whereas standard gastroenterological care did not alleviate pain or improve quality of life. There is minimal research trialing integrated models of care for the diagnosis and management of functional gastrointestinal disorders. This represents a lost opportunity for timely and effective healthcare provision to a large patient group. Although low in quality, preliminary data suggest that integrated nurse-led models of care are economically viable and may facilitate timely diagnosis and management and improve patient outcomes. Furthermore, studies to robustly evaluate the efficacy, safety, and acceptability of such models are needed.


  • Performance of an algorithm‐based approach to the diagnosis and management of functional gastrointestinal disorders: A pilot trial

    by E. C. Linedale, A. Mikocka‐Walus, A. D. Vincent, P. R. Gibson, J. M. Andrews

    Background: Recent advances in the development of diagnostic criteria and effective management options for functional gastrointestinal disorders (FGIDs) have not yet been integrated into clinical practice. There is a clear need for the development and validation of a simple clinical pathway for the diagnosis and management of FGIDs which can be used in primary care.Methods: In this controlled pilot study, we designed and evaluated a non‐specialist‐dependent, algorithm‐based approach for the diagnosis and management of FGIDs (ADAM‐FGID). Patients referred to 1 tertiary referral center with clinically suspected functional gastrointestinal disorders were allocated to waitlist control or algorithm group. The algorithm group was screened for organic disease, and those without clinical alarms received a written FGID diagnosis and management options. All participants were followed up for 1 year.Key Results: The ADAM‐FGID was found to be feasible and acceptable to both patients and primary healthcare providers. The diagnostic component identified that 39% of referrals required more urgent gastroenterological review than original triage category, with organic disease subsequently diagnosed in 31% of these. The majority of patients (82%) diagnosed with a FGID did not receive a relevant alternative diagnosis during follow‐up. Patient buy‐in to the model was good, with all reading the diagnostic/management letter, 80% entering management, and 61% reporting symptom improvement at 6 weeks. Moreover, 68% of patients and all referring doctors found the approach to be at least moderately acceptable. Patients reported being reassured by the approach and found the management options useful. Primary healthcare providers acknowledged the potential of this approach to reduce waiting times for endoscopic procedures and to provide reassurance to both patients and themselves.Conclusions & Inferences: This pilot study provides preliminary evidence to support a clinical pathway for the diagnosis and management of FGIDs which does not depend upon specialist review. Further rigorous testing within primary care is needed to conclusively establish safety and efficacy. However, this approach is safer than current management and has potential to build capacity by reducing specialist burden and expediting effective care.


  • Open Access

    Referrals to a tertiary hospital: A window into clinical management issues in functional gastrointestinal disorders

    by Ecushla C Linedale, Muhammad A Shahzad, Andrew R Kellie, Antonina Mikocka‐Walus, Peter R Gibson, Jane M Andrews

    Background and Aim: To investigate the quality of and reasons for referrals of patients with likely functional gastrointestinal disorders (FGID) and explore patients’ experience of clinical management.Methods: A cross sectional, mixed‐methods study was undertaken. Referrals (July 2013–2015) to one gastroenterology outpatient department triaged as “likely FGID”, the referred patients and their referring primary healthcare providers were examined.Results: A total of 69% of patients reported not yet receiving an initial diagnosis, 52% reported persistent/distressing symptoms or reduced quality of life, 24% feared missed or worsening pathology, and 35% were seeking repeat specialist consultation. Most patients were dissatisfied (40%) or only partially satisfied (36%) with current management. Dissatisfaction was significantly related to the lack of provision of a diagnosis and effective treatment options (P < 0.001). Referral quality was poor and with the reason for referral clearly communicated in only 25%. Common referral reasons included repeat presentations (n = 32), diagnostic uncertainty (n = 19), to ensure nothing is missed (n = 19), patient request (n = 17), no response to treatment (n = 16), and to allay patient fears (n = 14). A total of 28/60 primary healthcare providers were confident that their patient had a FGID, yet sought confirmation (n = 16), second opinion (n = 8), or advice (n = 4).Conclusion: Current management of FGID in usual care is suboptimal, as evidenced by the tertiary referral load, patient dissatisfaction, and the lack of provision of diagnoses and effective treatment options. Some clinicians lack confidence in effectively identifying and managing these conditions. Resources and supports to equip and assist clinicians to identify and manage FGID successfully may enhance patient care.